Does the media prefer AVR or ATRC?

In the previous week, Anteris Technologies Global had 12 more articles in the media than AtriCure. MarketBeat recorded 17 mentions for Anteris Technologies Global and 5 mentions for AtriCure. AtriCure's average media sentiment score of 1.12 beat Anteris Technologies Global's score of 1.00 indicating that AtriCure is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 4 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AtriCure 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TMDX or AVR?

In the previous week, Anteris Technologies Global had 5 more articles in the media than TransMedics Group. MarketBeat recorded 17 mentions for Anteris Technologies Global and 12 mentions for TransMedics Group. Anteris Technologies Global's average media sentiment score of 1.00 beat TransMedics Group's score of 0.64 indicating that Anteris Technologies Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anteris Technologies Global 4 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AVR or BFLY?

In the previous week, Anteris Technologies Global and Anteris Technologies Global both had 17 articles in the media. Anteris Technologies Global's average media sentiment score of 1.00 beat Butterfly Network's score of 0.35 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 4 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Butterfly Network 4 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to INSP or AVR?

In the previous week, Anteris Technologies Global had 10 more articles in the media than Inspire Medical Systems. MarketBeat recorded 17 mentions for Anteris Technologies Global and 7 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.45 beat Anteris Technologies Global's score of 1.00 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anteris Technologies Global 4 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AVR or AXGN?

In the previous week, Anteris Technologies Global had 7 more articles in the media than AxoGen. MarketBeat recorded 17 mentions for Anteris Technologies Global and 10 mentions for AxoGen. Anteris Technologies Global's average media sentiment score of 1.00 beat AxoGen's score of 0.54 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 4 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AxoGen 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Anteris Technologies Global (AVR) Competitors

$6.33 -0.12 (-1.88%)

As of 10:56 AM Eastern

Compare

AVR vs. ATRC, TMDX, BFLY, INSP, and AXGN

Should you buy Anteris Technologies Global stock or one of its competitors? Anteris Technologies Global's main competitors and comparable companies include AtriCure (ATRC), TransMedics Group (TMDX), Butterfly Network (BFLY), Inspire Medical Systems (INSP), and AxoGen (AXGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Anteris Technologies Global compare to AtriCure?

Anteris Technologies Global (NASDAQ:AVR) and AtriCure (NASDAQ:ATRC) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Anteris Technologies Global presently has a consensus target price of $14.00, indicating a potential upside of 117.05%. AtriCure has a consensus target price of $54.10, indicating a potential downside of 4.87%. Given Anteris Technologies Global's higher probable upside, equities analysts clearly believe Anteris Technologies Global is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
AtriCure	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58

In the previous week, Anteris Technologies Global had 12 more articles in the media than AtriCure. MarketBeat recorded 17 mentions for Anteris Technologies Global and 5 mentions for AtriCure. AtriCure's average media sentiment score of 1.12 beat Anteris Technologies Global's score of 1.00 indicating that AtriCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	4 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	329.12	-$94.14M	-$1.95	N/A
AtriCure	$534.53M	5.41	-$11.45M	$0.21	270.81

Anteris Technologies Global has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market. Comparatively, AtriCure has a beta of 1.24, meaning that its share price is 24% more volatile than the broader market.

AtriCure has a net margin of 1.85% compared to Anteris Technologies Global's net margin of -4,619.27%. AtriCure's return on equity of 2.34% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
AtriCure	1.85%	2.34%	1.77%

99.1% of AtriCure shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by insiders. Comparatively, 4.0% of AtriCure shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

AtriCure beats Anteris Technologies Global on 11 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and Anteris Technologies Global (NASDAQ:AVR) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

TransMedics Group has a beta of 1.94, indicating that its share price is 94% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.87, indicating that its share price is 87% more volatile than the broader market.

TransMedics Group currently has a consensus price target of $115.60, suggesting a potential upside of 46.07%. Anteris Technologies Global has a consensus price target of $14.00, suggesting a potential upside of 117.05%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts plainly believe Anteris Technologies Global is more favorable than TransMedics Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.33
Anteris Technologies Global	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

99.7% of TransMedics Group shares are held by institutional investors. 6.9% of TransMedics Group shares are held by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Anteris Technologies Global had 5 more articles in the media than TransMedics Group. MarketBeat recorded 17 mentions for Anteris Technologies Global and 12 mentions for TransMedics Group. Anteris Technologies Global's average media sentiment score of 1.00 beat TransMedics Group's score of 0.64 indicating that Anteris Technologies Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Anteris Technologies Global	4 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransMedics Group has a net margin of 22.69% compared to Anteris Technologies Global's net margin of -4,619.27%. TransMedics Group's return on equity of 15.88% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	22.69%	15.88%	5.95%
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%

TransMedics Group has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$605.49M	4.52	$190.29M	$3.89	20.34
Anteris Technologies Global	$1.91M	329.12	-$94.14M	-$1.95	N/A

Summary

TransMedics Group beats Anteris Technologies Global on 11 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to Butterfly Network?

Anteris Technologies Global (NASDAQ:AVR) and Butterfly Network (NYSE:BFLY) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

37.9% of Butterfly Network shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by insiders. Comparatively, 22.0% of Butterfly Network shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Anteris Technologies Global presently has a consensus target price of $14.00, suggesting a potential upside of 117.05%. Butterfly Network has a consensus target price of $8.75, suggesting a potential upside of 7.69%. Given Anteris Technologies Global's higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Butterfly Network	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75

Butterfly Network has higher revenue and earnings than Anteris Technologies Global. Butterfly Network is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	329.12	-$94.14M	-$1.95	N/A
Butterfly Network	$97.61M	22.17	-$77.06M	-$0.29	N/A

Anteris Technologies Global has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market. Comparatively, Butterfly Network has a beta of 2.04, indicating that its stock price is 104% more volatile than the broader market.

In the previous week, Anteris Technologies Global and Anteris Technologies Global both had 17 articles in the media. Anteris Technologies Global's average media sentiment score of 1.00 beat Butterfly Network's score of 0.35 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	4 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Butterfly Network	4 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Butterfly Network has a net margin of -66.74% compared to Anteris Technologies Global's net margin of -4,619.27%. Butterfly Network's return on equity of -33.99% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
Butterfly Network	-66.74%	-33.99%	-22.96%

Summary

Butterfly Network beats Anteris Technologies Global on 12 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to Inspire Medical Systems?

Inspire Medical Systems (NYSE:INSP) and Anteris Technologies Global (NASDAQ:AVR) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

Inspire Medical Systems has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.87, indicating that its share price is 87% more volatile than the broader market.

Inspire Medical Systems has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$911.98M	2.18	$145.42M	$4.62	14.89
Anteris Technologies Global	$1.91M	329.12	-$94.14M	-$1.95	N/A

Inspire Medical Systems has a net margin of 15.03% compared to Anteris Technologies Global's net margin of -4,619.27%. Inspire Medical Systems' return on equity of 8.64% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	15.03%	8.64%	7.45%
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%

In the previous week, Anteris Technologies Global had 10 more articles in the media than Inspire Medical Systems. MarketBeat recorded 17 mentions for Anteris Technologies Global and 7 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.45 beat Anteris Technologies Global's score of 1.00 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Anteris Technologies Global	4 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

94.9% of Inspire Medical Systems shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by insiders. Comparatively, 4.5% of Anteris Technologies Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Inspire Medical Systems presently has a consensus target price of $67.88, suggesting a potential downside of 1.32%. Anteris Technologies Global has a consensus target price of $14.00, suggesting a potential upside of 117.05%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than Inspire Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	4 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.05
Anteris Technologies Global	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Inspire Medical Systems beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to AxoGen?

Anteris Technologies Global (NASDAQ:AVR) and AxoGen (NASDAQ:AXGN) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

In the previous week, Anteris Technologies Global had 7 more articles in the media than AxoGen. MarketBeat recorded 17 mentions for Anteris Technologies Global and 10 mentions for AxoGen. Anteris Technologies Global's average media sentiment score of 1.00 beat AxoGen's score of 0.54 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	4 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AxoGen	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

80.3% of AxoGen shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by insiders. Comparatively, 2.4% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Anteris Technologies Global has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

AxoGen has higher revenue and earnings than Anteris Technologies Global. AxoGen is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	329.12	-$94.14M	-$1.95	N/A
AxoGen	$225.21M	8.63	-$15.70M	-$0.68	N/A

Anteris Technologies Global currently has a consensus price target of $14.00, indicating a potential upside of 117.05%. AxoGen has a consensus price target of $51.73, indicating a potential upside of 43.01%. Given Anteris Technologies Global's higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
AxoGen	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.80

AxoGen has a net margin of -13.36% compared to Anteris Technologies Global's net margin of -4,619.27%. AxoGen's return on equity of -8.90% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
AxoGen	-13.36%	-8.90%	-6.47%

Summary

AxoGen beats Anteris Technologies Global on 10 of the 17 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVR vs. The Competition

Export

Metric	Anteris Technologies Global	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$615.56M	$5.55B	$7.26B	$13.10B
Dividend Yield	N/A	1.75%	2.52%	22.89%
P/E Ratio	-3.24	25.60	275.54	25.58
Price / Sales	322.94	67.27	557.67	80.26
Price / Cash	N/A	32.25	77.16	53.04
Price / Book	-632.90	5.82	10.81	6.02
Net Income	-$94.14M	$146.14M	$3.49B	$380.34M
7 Day Performance	-7.20%	-1.38%	-3.00%	-3.19%
1 Month Performance	-27.42%	-4.06%	-7.48%	-6.07%
1 Year Performance	38.49%	0.95%	3.18%	-3.77%

Anteris Technologies Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVR Anteris Technologies Global	2.7588 of 5 stars	$6.33 -1.9%	$14.00 +121.2%	+44.9%	$615.56M	$1.91M	N/A	174	Analyst Forecast Gap Up
ATRC AtriCure	2.4555 of 5 stars	$56.37 +2.2%	$53.30 -5.4%	+59.7%	$2.80B	$534.53M	268.44	1,350	Positive News Analyst Forecast
TMDX TransMedics Group	4.065 of 5 stars	$82.99 +4.0%	$121.10 +45.9%	-29.2%	$2.76B	$605.49M	21.33	898	Analyst Forecast
BFLY Butterfly Network	2.8239 of 5 stars	$9.41 +5.1%	$8.54 -9.2%	+254.0%	$2.38B	$97.61M	N/A	220	Analyst Forecast
INSP Inspire Medical Systems	2.7107 of 5 stars	$70.77 +1.1%	$67.44 -4.7%	-11.3%	$2.02B	$911.98M	15.32	1,333	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AVR) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Anteris Technologies Global (AVR) Competitors

AVR vs. ATRC, TMDX, BFLY, INSP, and AXGN

How does Anteris Technologies Global compare to AtriCure?

Summary

How does Anteris Technologies Global compare to TransMedics Group?

Summary

How does Anteris Technologies Global compare to Butterfly Network?

Summary

How does Anteris Technologies Global compare to Inspire Medical Systems?

Summary

How does Anteris Technologies Global compare to AxoGen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVR vs. The Competition

Anteris Technologies Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Anteris Technologies Global (AVR) Competitors

AVR vs. ATRC, TMDX, BFLY, INSP, and AXGN

How does Anteris Technologies Global compare to AtriCure?

Do analysts recommend AVR or ATRC?

Does the media prefer AVR or ATRC?

Which has preferable valuation and earnings, AVR or ATRC?

Which has more risk & volatility, AVR or ATRC?

Is AVR or ATRC more profitable?

Do insiders and institutionals believe in AVR or ATRC?

Summary

How does Anteris Technologies Global compare to TransMedics Group?

Which has more risk & volatility, TMDX or AVR?

Do analysts recommend TMDX or AVR?

Do insiders and institutionals believe in TMDX or AVR?

Does the media refer more to TMDX or AVR?

Is TMDX or AVR more profitable?

Which has stronger earnings & valuation, TMDX or AVR?

Summary

How does Anteris Technologies Global compare to Butterfly Network?

Do insiders & institutionals hold more shares of AVR or BFLY?

Do analysts prefer AVR or BFLY?

Which has higher earnings and valuation, AVR or BFLY?

Which has more risk and volatility, AVR or BFLY?

Does the media refer more to AVR or BFLY?

Is AVR or BFLY more profitable?

Summary

How does Anteris Technologies Global compare to Inspire Medical Systems?

Which has more volatility & risk, INSP or AVR?

Which has better valuation & earnings, INSP or AVR?

Is INSP or AVR more profitable?

Does the media refer more to INSP or AVR?

Do insiders & institutionals believe in INSP or AVR?

Do analysts recommend INSP or AVR?

Summary

How does Anteris Technologies Global compare to AxoGen?

Does the media favor AVR or AXGN?

Do insiders & institutionals believe in AVR or AXGN?

Which has more volatility and risk, AVR or AXGN?

Which has higher valuation & earnings, AVR or AXGN?

Do analysts recommend AVR or AXGN?

Is AVR or AXGN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVR vs. The Competition

Anteris Technologies Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools